Fig. 1From: Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative studyPFS and OS between groups. Comparison of PFS (A) and OS (B) between bevacizumab plus chemo group and chemo groupBack to article page